Venous tolerance to etomidate in lipid emulsion or propylene glycol (hypnomidate)
Doenicke
A
A
Kugler
A
A
Vollmann
N
N
D000293:Adolescent; D000328:Adult; D000368:Aged; D000771:Anesthesia, Intravenous / Q000009:adverse effects; D004338:Drug Combinations; D004655:Emulsions / Q000494:pharmacology*; D005026:Ethylene Glycols / Q000494:pharmacology*; D005045:Etomidate / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D014677:Pharmaceutical Vehicles / Q000494:pharmacology; D010689:Phlebitis / Q000209:etiology; D010743:Phospholipids / Q000494:pharmacology*; D011897:Random Allocation; D016037:Single-Blind Method; D013012:Sorbitol / Q000494:pharmacology*; D013924:Thrombophlebitis / Q000209:etiology
D004338:Drug Combinations; D004655:Emulsions; D005026:Ethylene Glycols; D014677:Pharmaceutical Vehicles; D010743:Phospholipids; C008288:Lipofundin; D013012:Sorbitol; D005045:Etomidate